Home > Assaf Hilely, ESCRS 2020 – Non-neovascular Age-related Macular Degeneration with Subretinal Fluid
Macular Degeneration

Assaf Hilely, ESCRS 2020 – Non-neovascular Age-related Macular Degeneration with Subretinal Fluid

Published Online: October 8th 2020

We caught up with Editorial Board member Dr Assaf Hilely (Tel Aviv Medical Center, Tel Aviv, Israel), who talked us through his recent study of non-neovascular age-related macular degeneration with subretinal fluid.

Questions

  1. What prognostic factors are currently used to guide treatment when initiating anti-vascular endothelial growth factor treatment for patients with age-related macular degeneration (AMD) with and without neovascularisation? (00:07)
  2. What was the rationale for investigating patterns of subretinal fluid in eyes with AMD without neovascularisation? (01:22)
  3. Could you tell us a little about the aims and design of your recent study? (02:12)
  4. What were the findings of the study? (03:20)
  5. What will be the impact of these findings on clinical practice and what future studies are planned? (04:53)

Speaker Disclosure: Dr Assaf Hilely has no financial or non-financial relationships or activities to declare in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of ESCRS 2020.

Share this Video
Related Videos In Macular Degeneration
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar